ImmunityBio: Company Leaves 2021 On A High-Note; Share Price Still Falls Flat
Published on: Monday 27 December 2021
ImmunityBio is preparing to submit their BLA in NMIBC in the first quarter of 2022. The company is moving forward with several COVID-19 vaccine programs with different technologies.
News source: https://seekingalpha.com/article/4476969-immunitybio-company-leaves-2021-on-a-high-note-share-price-still-falls-flat
